Pulmonary hypertension in chronic lung disease of infancy: Pathogenesis, pathophysiology, and treatment

Chronic Lung Disease in Early Infancy

Volumn , Issue , 1999, Pages 619-668

  Abman, Steven H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84986195082     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (321)

1. Abman SH, Accurso FJ. Acute effects of partial compression of the ductus arteriosus on the fetal pulmonary circulation. Am J Physiol 1989; 257:H626-634.
2. Abman SH, Accurso FJ. Sustained fetal pulmonary vasodilation during prolonged infusion of atrial natriuretic factor and 8-bromo-guanosine monophosphate. Am J Physiol 1991; 260:H183-192.
3. Abman SH, Accurso FJ, Bowman CM. Unsuspected cardiopulmonary abnormalities in infants with BPD. Arch Dis Child 1984; 59:966-970.
4. Abman SH, Accurso FJ, Koops BL. Experience with home oxygen in the management of infants with BPD. Clin Pediatr 1984; 23:471-476.
5. Abman SH, Burchell MF, Schaffer MS, Rosenberg AA. Late sudden unexpected deaths in hospitalized infants with BPD. Am J Dis Child 1989; 143:815-819.
6. Abman SH, Chatfield BA, Hall SL, McMurtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990; 259:H1921-1927.
7. Abman SH, Chatfield BA, Rodman DM, Hall SL, McMurtry IF. Maturation-related changes in endothelium-dependent relaxation of ovine pulmonary arteries. Am J Physiol 1991; 260:L280-285.
8. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effects of inhaled NO in children with severe hypoxemic respiratory failure. J Pedi- atr 1994; 124:881-888.
9. Abman SH, Groothius JR. Pathophysiology and treatment of BPD. Current issues. Pediatr Clin North Am 1994; 41:277-315.
10. Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. Inhaled nitric oxide therapy in a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 1993; 92:606-609.
11. Abman SH, Schaffer MS, Wiggins JW, Washington RL, Manco-Johnson M, Wolfe RR. Pulmonary vascular extraction of circulating norepinephrine in infants with BPD. Pediatr Pulmonol 1987; 3:386-391.
12. Abman SH, Shanley PF, Accurso FJ. Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J Clin Invest 1989; 83:1849-1858.
13. Abman SH, Sondheimer HM. Pulmonary circulation and cardiovascular sequelae of BPD. In: Weir. EK, Archer SL, Reeves JT, eds. Diagnosis and Treatment of Pulmonary Hypertension. Mount Kisco, NY: Futura Publishing, 1992:155-180.
14. Abman SH, Wolfe RR, Accurso FJ, Koops BL, Bowman CM, Wiggins JW. Pulmonary vascular response to oxygen in infants with severe BPD. Pediatrics 1985; 75: 80-84.
15. Accurso FJ, Alpert B, Wilkening RB, Petersen RG, Meschia G. Time-dependent response of fetal pulmonary blood flow to an increase in fetal oxygen tension. Respir Physiol 1986; 63:43-52.
16. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrier PE. Loss of endothelium- dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991; 87:155-162.
17. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8:504-512.
18. Albertine KH, Kim BI, Kullama LK, Carlton DP, Bland RD. Prolonged mechanical ventilation of preterm lambs leads to smooth muscle extension and elastin accumulation along pulmonary blood vessels. Pediatr Res 1996; 39:323A.
19. Allen K, Haworth SG. Impaired adaptation of intrapulmonary arteries to extrauter- ine life in newborn pigs exposed to hypoxia. an ultrastructural study. Fed Proc 1986; 45:879.
20. Allen SW, Chatfield BA, Koppenhafer SL, Schaffer MS, Wolfe RR, Abman SH. Circulating immunoreactive ET-1 in children with pulmonary hypertension: association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis 1993; 148: 519-522.
21. Anderson WR, Engel RR. Cardiopulmonary sequelae of reparative stages of BPD. Arch Pathol Lab Med 1983; 107:603-608.
22. Archer SL, Huang JMC, Hampl V, Nelson DP, Shultz PJ, Weir EK. NO and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 1994; 91:7583-7587.
23. Arnal J-F, Yamin J, Dockery S, Harrison DG. Regulation of endothelial NO synthase mRNA, protein, and activity during cell growth. Am J Physiol 1994; 267: C1381-1388.
24. Arnold WP, Mittal CK, Katsuki S, Murad F. NO activates guanylate cyclase and increases guanosine 3'-5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 1977; 74:3203-3207.
25. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with BPD. Pediatrics 1985; 75:106-111.
26. Bader D, Ramos AD, Lew CD, et al. Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after BPD. J Pediatr 1987; 110: 693-699.
27. Badesch D, Orton E, Zapp L, Westcott J, Hester J, Voelkel N, Stenmark K. Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension. Am J Respir Cell Mol Biol 1989; 1:489-498.
28. Banarjee CK, Girling WJ, Wigglesworth JS. Pulmonary fibroplasia in newborn babies treated with oxygen and artificial ventilation. Arch Dis Child 1972; 47:509-518.
29. Barbera JA, Roger N, Roca J, et al. Worsening of pulmonary gas exchange with NO inhalation in COPD. Lancet 1996; 347:436-440.
30. Barer GR, Cai Y, Russell PC, Emery CJ. Reactivity and sites of vasomotion in pulmonary vessels of chronically hypoxic rats: relation to structural changes. Am Rev Respir Dis 1989; 140:1483-1485.
31. Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Int Med 1994; 121:409-415.
32. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epo- prostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334:296-301, 1996.
33. Baylen BG, Emmanouillides GC, Juratsch CE, Yoshida Y, French WJ, Criley JM. Main pulmonary artery distension: a potential mechanism for acute pulmonary hypertension in the human newborn infant. J Pediatr 1980; 96:540-544.
34. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990; 11:150-155.
35. Beckerman RC. Unexpected deaths in infants monitored at home. Am J Dis Child 1988; 142:1033-1034.
36. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from NO and superoxide. Proc Natl Acad Sci USA 1990; 87:1620-1624.
37. Belik J, Halayko AJ, Rao K, Stephens NL. Fetal ductus arteriosus ligation: pulmonary vascular smooth muscle biochemical and mechanical changes. Circ Res 1993; 72:588-596.
38. Belik J, Sienko A, Light RB. The effect of repeated intermittent hypoxia on pulmonary vasoconstriction in the newborn. Can J Physiol Pharmacol 1990; 68:355-362.
39. Belik J, Stephens NL. Developmental differences in vascular smooth muscle mechanics in pulmonary and systemic circulations. J Appl Physiol 1993; 74:682-687.
40. Bell EF, Warburton D, Stonestreet BS, Oh W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 1980; 302:598-604.
41. Benatar A, Clarke J, Silverman M. Pulmonary hypertension in infants with chronic lung disease: noninvasive evaluation and short term effect of oxygen treatment. Arch Dis Child 1995; 72:F14-19.
42. Benzing A, Brautigan P, Geiger K, et al. Inhaled NO reduces pulmonary transvascu- lar albumin flux in patients with acute lung injury. Anesthesiology 1995; 83:1153-1161.
43. Berman W, Yabek SM, Dillon T, Burstein R, Corlew S. Evaluation of infants with BPD using cardiac catheterization. Pediatrics 1982; 70:708-712.
44. Berman W, Katz R, Yabek SM, Dillon T, Fripp RR, Papile LA. Long term follow- up of BPD. J Pediatr 1986; 109:45-50.
45. Boat TF, Kleinerman JI, Fanaroff AA, Matthews LW. Toxic effects of oxygen on cultured human neonatal respiratory epithelium. Pediatr Res 1973; 7:607-615.
46. Bolotina VM, Najibi S, Palacino JJ, Pagano PH, Cohen RA. NO directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994; 368:850-853.
47. Bonikos DS, Bensch KG, Northway WH, Edwards DK. BPD: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis. Hum Pathol 1976; 7:623-650.
48. Bonvallet ST, Zamoral MA, Hasunuma K, Sato K, Hanasato N, Anderson D, Sato K, Stelzner TJ. BQ123, an ET A-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am J Physiol 1994; 266:H1327-1331.
49. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85:587-590.
50. Boyden EA. The time lag in the development of bronchial arteries. Anat Rec 1970; 166:611-614.
51. Braner DA, Fineman JR, Chang R, et al. M and B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs. Am J Physiol 1993; 264:H252- 258.
52. Brannon TS, North AJ, Wells LB, Shaul PW. Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression. J Clin Invest 1994; 93:2230-2235.
53. Bressack MA, McMillan DD, Bland RD. Pulmonary oxygen toxicity: increased microvascular permeability to protein in unanesthetized lambs. Lymphology 1979; 12:133-139.
54. Brown ER, Stark A, Sosenko I, Lawson EE, Avery ME. BPD: possible relationship to pulmonary edema. J Pediatr 1978; 92:982-984.
55. Brownlee JR, Beekman RH, Rosenthal A. Acute hemodynamic effects of nifedipine in infants with BPD and pulmonary hypertension. Pediatr Res 1988; 24:186-190.
56. Bryan MH, Hardie MJ, Reilly BJ, Swyer PR. Pulmonary function studies during the first year of life in infants recovering from respiratory distress syndrome. Pediatrics 1973; 52:169-178.
57. Bush A, Busst CM, Knight WB, Hislop AA, Haworth SG, Shinebourne EA. Changes in pulmonary circulation in severe BPD. Arch Dis Child 1990; 65:739-745.
58. Carlton DP, Cummings JJ, Sheerer RS, et al. Lung overexpansion increases pulmonary microvascular protein permeability in young lambs. J Appl Physiol 1990; 69: 577-583.
59. Carlton DP, Cho SC, Davis P, Lont M, Bland RD. Surfactant treatment at birth reduces lung vascular injury and edema in preterm lambs. Pediatr Res 1995; 37: 265-270.
60. Cassin S. Role of prostaglandins, thromboxanes and leukotrienes in the control of the pulmonary circulation in the fetus and newborn. Semin Perinatol 1987; 11:53-63.
61. Cassin S, Dawes GS, Mott JC, Ross BB, Strang LB. Vascular resistance of the foetal and newly ventilated lung of the lamb. J Physiol 1964; 171:61-79.
62. Cassin S, Gause G, Davis T, ter Riet M, Baker R. Do inhibitors of lipoxygenase and cyclooxygenase block neonatal hypoxic pulmonary vasoconstriction? J Appl Physiol 1988; 66:1779-1784.
63. Cassin S, Kristova T, Davis T, Kadowitz P, Gause G. Tone-dependent responses to endothelin in the isolated perfused fetal sheep pulmonary circulation in situ. J Appl Physiol 1991; 70:1228-1234.
64. Chatfield BA, McMurtry IF, Hall SL, Abman SH. Hemodynamic effects of endo- thelin-1 on the ovine fetal pulmonary circulation. Am J Physiol 1991; 261:R182-187.
65. Charon A, Taeusch HW, Fitzgibbon C, Smith GB, Treves ST, Phelps DS. Factors associated with surfactant response in infants with severe RDS. Pediatrics 1989; 83:348-354.
66. Chollet-Martin S, Gatecel C, Kermarrec N, et al. Alveolar neutrophil functions and cytokine levels in patients with the ARDS during NO inhalation. Am J Respir Crit Care Med 1996; 153:985-990.
67. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Lloyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327:1732-1739.
68. Chu J, Clements JA, Cotton EK, Klaus MH, Sweet AY, Tooley WH. Neonatal pulmonary ischemia. Part 1. Clinical and physiologic studies. Pediatrics 1967; 40: 709-782.
69. Chu J, Clements JA, Cotton EK, Klaus MH, Sweet AY, Thomas MA, Tooley WH. The pulmonary hypoperfusion syndrome. Pediatrics 1965; 35:733-742.
70. Gerstmann DR, Minton SD, Stoddard RA, et al. The Provo Multicenter Early High Frequency Oscillatory Ventilation Trial: improved pulmonary and clinical outcome in RDS. Pediatrics 1996; 98:1044-1057.
71. Clark RH, Gerstmann DR, Null DM, deLemos RA. Prospective randomized comparison of high frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 1992; 89:5-12.
72. Coalson JJ, Kuehl TJ, Escobeda MB, et al. Baboon model of BPD. II: Pathologic features. Exp Mol Pathol 1982; 37:335-350.
73. Coalson JJ, Winter VT, deLemos RA. Decreased alveolarization in baboon survivors with BPD. Am J Respir Crit Care Med 1995; 152:640-646.
74. Coflesky JT, Jones R, Reid L, Evans JN. Mechanical properties and structure of isolated pulmonary arteries remodeled by chronic hyperoxia. Am Rev Resir Dis 1987; 136:388-394.
75. Cohen AH, Hanson K, Morris K, Fouty B, McMurtry IF, Clarke W, Rodman DM. Inhibition of cGMP-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats. J Clin Invest 1996; 97:172-179.
76. Collaborative European Multicenter Study Group. Factors influencing the clinical response to surfactant replacement therapy in babies with severe RDS. Eur J Pediatr 1991; 150:433-439.
77. Cooke JP, Rossitch E, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrosovasodilator. J Clin Invest 1991; 88:1663-1671.
78. Cooper CJ, Landzberg MJ, Anderson TJ, et al. Role of NO in the local regulation of pulmonary vascular resistance in humans. Circulation 1996; 93:266-271.
79. Corbridge TC, Wood LDH, Crawford GP, et al. Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am Rev Respir Dis 1990; 142:31-1315.
80. Cornfield DN, Chatfield BA, McQueston JA, McMurtry IF, Abman SH. Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in the ovine fetus. Am J Physiol 1992; 262:H1474-1481.
81. Cornfield DN, McQueston JA, McMurtry IF, Rodman DM, Abman SH. Role of ATP-sensitive K+-channels in ovine fetal pulmonary vascular tone. Am J Physiol 1992; 263:H1363-1368.
82. Cornfield DN, Reeve HL, Tolarova S, Weir EK, Archer S. Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc Natl Acad Sci USA 1996; 93:8089-8094.
83. Cornfield D, Stevens T, McMurtry I, Abman S, Rodman D. Acute hypoxia causes membrane depolarization and influx in fetal pulmonary artery smooth muscle cells. Am J Physiol 1994; 266:L469-L475.
84. Crawley DE, Zhao L, Giemycz MA, Liu S, Barnes PJ, Winter RJD, Evans TW. Chronic hypoxia impairs soluble guanylate cyclase-mediated pulmonary arterial relaxation in the rat. Am J Physiol 1992; 263:L325-332.
85. Cremona G, Wood AM, Hall LW, Bower EA, Higenbottam T. Effect of inhibitors of NO release and action on vascular tone in isolated lungs of pig, sheep, dog and man. J Physiol 1994; 481.1:185-195.
86. Davidson D. Pulmonary hemodynamics at birth: effect of acute cyclooxygenase inhibition in lambs. J Appl Physiol 1988; 64:1676-1682.
87. Davidson D, Eldemerdash A. Endothelium-derived relaxing factor: evidence that it regulates pulmonary vascular resistance in the isolated newborn guinea pig lung. Pediatr Res 1991; 29:538-542.
88. Davies G, Reid LM. Growth of the alveoli and pulmonary arteries in childhood. Thorax 1970; 25:669-681.
89. Davis WB, Rennard SI, Bitterman PB, Crystal RG. Pulmonary oxygen toxicity. N Engl J Med 1983; 309:878-883.
90. Dawes GS. Foetal and Neonatal Physiology. Chicago: Year Book, 1968.
91. Dawes GS, Mott JC. The vascular tone of the foetal lung. J Physiol 1962; 164: 465-477.
92. De Caterina R, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK. NO decreases cytokine-induced endothelial activation. NO selectively reduces endothelial expression of adhesion molecules and proinflam- matory cytokines. J Clin Invest 1995; 96:60-68.
93. deLemos RA, Coalson JJ. The contribution of experimental models to our understanding of the pathogenesis and treatment of BPD. Clin Perinatol 1992; 19:521539.
94. deLemos RA, Coalson JJ, Gerstmann DR, Keuhl TJ, Null DM. Oxygen toxicity in the premature baboon with hyaline membrane disease. Am Rev Respir Dis 1988; 136:677-682.
95. deLemos R, Wolsdorf J, Nachman R, Block AJ, Leiby G, Wolkinson HA, Allen T, Haller A, Avery ME. Lung injury from oxygen in lambs. The role of artificial ventilation. Anesthesiology 1969; 30:609-618.
96. DeRuiter MC, Grittenberger-DeGroot AC, Rammos S, Poelmann RE. The special status of the pulmonary artery in the branchial arch system of the rat. Anat Embryol 1990; 181:341-349.
97. Dreyfuss D, Basset G, Soler P, et al. Intermittent positive pressure hyperventilation with high inflation pressure produces microvascular injury in rats. Am Rev Respir Dis 1985; 132:880-884.
98. Dreyfuss D, Soler P, Basset G, et al. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137:1159-1164.
99. Druml W, Steltzer H, Waldhausl W, Lenz K, Hammerle A, Vierhapper H, Gasic S, Wagner OF. Endothelin-1 in ARDS. Am Rev Respir Dis 1993; 148:1169-1173.
100. Dubin D, Pratt RE, Cooke JP, Dzau VJ. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1989; 1:150-154.
101. Emmanouilides GC, Moss AJ, Duffie ER, Adams FH. Pulmonary artery pressure changes in human newborn infants from birth to 3 days of age. J Pediatr 1964; 65: 327-333.
102. Enhorning G, Adams FH, Norman A. Effect of lung expansion on the fetal lamb circulation. Acta Paediatr Scand 1966; 55:441-451.
103. Erickson AM, de la Monte SM, Moore GW, Hutchins GM. Progression of morphologic changes in BPD. Am J Pathol 1987; 127:474-484.
104. Evans NJ, Archer LNJ. Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of HMD. Arch Dis Child 1991; 66: 24-26.
105. Evans NJ, Archer LN. Postnatal circulatory adaptation in healthy term and preterm infants. Arch Dis Child 1990; 65:24-26.
106. Fanburg B, Massaro D, Cerutti P, Gail D, Beberich M. Regulation of gene expression by O2 tension. Am J Physiol 1991; 264:L235-L241.
107. Fasules JW, Wiggins JW, Wolfe RR. Increased lung vasoreactivity in children from Leadville, Colorado, after recovery from high altitude pulmonary edema. Circulation 1985; 72:957-962.
108. Fineman JR, Heymann MA, Soifer SJ. Nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am J Physiol 1991; 260:1299-1306.
109. Finkelstein JN, Horowitz S, RA Sinkin, RM Ryan. Cellular and molecular responses to lung injury in relation to induction of tissue repair and fibrosis. Clin Perinatol 1992; 19:603-620.
110. Fouron JC, LeGuennec JC, Villemont D, Bard H, Pareult G, Davignon A. Value of echocardiography in assessing the outcome of BPD. Pediatrics 1980; 65:529-535.
111. Fox RB, Hoidal JR, Brown DM, Repine JE. Pulmonary inflammation due to O2 toxicity: involvement of chemotactic factors and PMNs. Am Rev Respir Dis 1982; 123:521-523.
112. Frank L. Oxidant injury to pulmonary endothelium. In: Said SI, ed. Pulmonary Circulation and Acute Lung Injury. New York: Futura, 1985:249-281.
113. Frank L, Bucher JR, Roberts RJ. O2 toxicity in neonatal and adult animals of various species. J Appl Physiol 1979; 45:699-704.
114. Fratacci M-D, Frostell CG, Chen TY, Zapol WM. Inhaled NO: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991; 75:990-999.
115. Freeman BA, Crapo JD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982; 47:412-426.
116. Freeman BA, Gutierrez H, Rubbo H. NO: a central regulatory species in pulmonary oxidant reactions. Am J Physiol 1995; 268:L697-698.
117. Froese AB, McCulloch PR, Sugiura M, et al. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis 1993; 148:569-577.
118. Fu Z, Costello ML, Tsukimoto K, et al. High lung volume increases stress failure in pulmonary capillaries. Appl Physiol 1992; 73:123-133.
119. Garg M, Kurzner SI, Batista D, et al. Hypoxic arousal responses in infants with BPD. Pediatrics 1988; 82:59-63.
120. Garg UC, Hassid A. NO-generating vasodilators and 8-bromo-cGMP inhibit mito- genesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83:17744-17747.
121. Geggel RL, Reid LM. The structural basis of persistent pulmonary hypertension of the newborn. Clin Perinatol, 1984; 3:525-549.
122. Gerlach H, Rossaint R, Pappert T, Falke KJ. Time course and dose-response of NO inhalation for systemic oxygenation and pulmonary hypertension in patients with ARDS. Eur J Clin Invest 1993; 23:499-502.
123. Gerritsen ME, Bloor CM. Endothelial gene expression in response to injury. FASEB J 1993; 7:523-532.
124. Gewitz MH, Pitt BR, Laks H, et al. Reversible changes in norepinephrine extraction by the lungs in children with pulmonary hypertension. Pediatr Pharmacol 1982; 2: 57-63.
125. Giaid A, Saleh D. Reduced expression of endothelial NO synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333:214-221.
126. Giaid A, Yanagasawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328:1732-1739.
127. Gibson RL, Jackson JC, Twiggs GA, et al. BPD: survival after prolonged mechanical ventilation. Am J Dis Child 1988; 142:721-725.
128. Gil AB, Weindling AM. Pulmonary artery pressure changes in the very-low birthweight infant developing chronic lung disease. Arch Dis Child 1993; 68:303307.
129. Golan E, Zalzstein E, Zmora E, Shinwell ES. Pulmonary hypertension in RDS. Pediatr Pulmonol 1995; 19:221-225.
130. Goldberg SJ, Levy RA, Siassi B. Effects of maternal hypoxia and hyperoxia upon the neonatal pulmonary vasculature. Pediatrics 1971; 48:528-533.
131. Golden CL, Kohler JP, Nick HS, Visner GA. Effects of vasoactive and inflammatory mediators on ET-1 expression in pulmonary endothelial cells. Am J Respir Cell Mol Biol 1995; 12:503-512.
132. Goodman G, Perkin RM, Anas NG, Sperling DR, Hicks DA, Rowen M. Pulmonary hypertension in infants with BPD. J Pediatr 1988; 112:67-72.
133. Gore RG, Jones R. Pulmonary vascular reactivity in hyperoxic pulmonary hypertension in the rat. J Appl Physiol 1988; 65:2617-2623.
134. Gorenflo M, Voge M, Obladen M. Pulmonary vascular changes in BPD: a clinico- pathologic correlation in short- and long-term survivors. Pediatr Pathol 1991; 11: 851-866.
135. Groneck P, Speer C. Inflammatory mediators and BPD. Arch Dis Child 1995; 73: F1-3.
136. Gutierrez HH, Nieves B, Chumley P, Rivera A, Freeman BA. NO regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered NO. Free Radic Biol Med 1996; 21:43-52.
137. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactant. Am J Physiol 1993; 265:L555-564.
138. Hakim TS, Mortola JP. Pulmonary vascular resistance in adult rats exposed to hypoxia in the neonatal period. Can J Physiol Pharmacol 1989; 68:419-424.
139. Halbower AC, Tuder RM, Franklin WA, Pollock JS, Forstermann U, Abman SH. Maturation-related changes in endothelial NO synthase immunolocalization in the developing ovine lung. Am J Physiol 1994; 267:L585-591.
140. Hall SM, Haworth SG. Normal adaptation of pulmonary arterial intima to extrauter- ine life in the pig. Ultrastructural studies. J Pathol 1986; 149:55-66.
141. Halliday HL, Dumpit FM, Brady JP. Effects of inspired oxygen on echocardio- graphic assessment of pulmonary vascular resistance and myocardial contractility in BPD. Pediatrics 1980; 65:536-540.
142. Hampl V, Herget J. Perinatal hypoxia increases hypoxic pulmonary vasoconstriction in adult rats recovering from chronic exposure to hypoxia. Am Rev Respir Dis 1990; 142:619-624.
143. Hampl V, Tristani-Firouzi M, Hutsell TC, Archer SL. Nebulized NO nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc Res 1996; 31:55-62.
144. Hansen TN, Corbet AJS, Kenny JD, Courtney JD, Rudolph AN. Effects of oxygen and constant positive pressure breathing on aDco2 in HMD. Pediatr Res 1979; 13: 1167-1171.
145. Harrod JR, L’Heureux P, Wangensteen OD, CE Hunt. Long-term follow-up of severe respiratory distress syndrome treated with IPPB. J Pediatr 1974; 84:277-286.
146. Haworth SG. Pulmonary vascular remodeling in neonatal pulmonary hypertension: state of the art. Chest 1988; 93:133S-138S.
147. Haworth SG. Pulmonary hypertension in childhood. Perspect Pediatr Pathol 1995; 18:71-110.
148. Haworth SG, Hislop AA. Pulmonary vascular development: normal values of peripheral vascular structure. Am J Cardiol 1983; 52:578-583.
149. Hazinski TA. BPD. In: Chernick V, ed. Kendig’s Disorders of the Respiratory Tract in Children, 5th ed. Philadelphia: WB Saunders, 1990:300-320.
150. Heymann MA, Soifer SJ. Control of fetal and neonatal pulmonary circulation. In: Weir EK, Reeves JT eds. Pulmonary Vascular Physiology and Pathophysiology. New York: Marcel Dekker, 1989: 33-50.
151. Higenbottam T, Wheeldon D, Wells F, Wallwork J. Longterm treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet 1984; 1:1046-1047.
152. Hislop AA, Haworth SG. Pulmonary vascular damage and the development of cor pulmonale following HMD. Pediatr Pulmonol 1990; 9:152-161.
153. Hislop AA, Reid L. Intrapulmonary arterial development during fetal life— branching pattern and structure. J Anat 1972; 113:35-48.
154. Hislop AA, Reid LM. Pulmonary arterial development during childhood: branching pattern and structure. Thorax 1973; 28:129-135.
155. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Graneot-Keros L, Duroux P, Galanaud P, Simmoneau G, Emllie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995; 151:1628-1631.
156. Ignarro LJ, Buga GM Buga, Wood KS, Byrns RE, Chaudhuri G. Endothelium- derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9269.
157. Ikegami M, Jacobs H, Jobe A. Surfactant function in respiratory distress syndrome. J Pediatr 1983; 102:443-447.
158. Imai T, Hirata Y, Emori T, Marumo F. Heparin has an inhibitory effect on endothelin- 1 synthesis and release by endothelial cells. Hypertension 1993; 21:353-358.
159. Imai Y, Kawano T, Miyasaka K, Takata M, Imai T, Okuyama R. Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Care Med 1994; 150:1550-1554.
160. Isaacson T, Hampl V, Weir E, Nelson D, Archer S. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J Appl Physiol 1994; 76:933-940.
161. Isozaki-Fukuda Y, Kojima T, Hirata Y, Ono A, Sawaragi S, Sawaragi T, Kobayashi Y. Plasma immunoreactive ET-1 concentration in human fetal blood: its relation to asphyxia. Pediatr Res 1991; 30:244-247.
162. Ivy DD, Kinsella JP, Abman SH. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest 1994; 93: 2141-2148.
163. Ivy DD, Ziegler JW, Dubus MF, Fox JJ, Kinsella JP, Abman SH. Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetus. Pediatr Res 1995; 39:335-342.
164. Ivy DD, Parker TA, Ziegler JW, Galan HL, Kinsella JP, Abman SH. Prolonged endothelin A receptor blockade attenuates chronic intrauterine pulmonary hypertension. J Clin Invest 1997; 99:1179-1186.
165. Ivy DD, Ziegler JW, Kinsella JP, Abman SH. Endothelin blockade augments fetal pulmonary vasodilation. J Appl Physiol 1996; 81:2481-2487.
166. Jobe A. Pulmonary surfactant therapy. N Engl J Med 1993; 328:861-868.
167. Jobe A, Ikegami M, Jacobs H, Jones S, Conaway D. Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J Appl Physiol 1983; 48:169-176.
168. Jones OW, Abman SH. Systemic and pulmonary hemodynamic effects of big endo- thelin-1 and phosphoramidon in the ovine fetus. Am J Physiol 1994; 266:R929-935.
169. Jones R, Zapol WM, Reid LM. Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. Am J Pathol 1984; 117:273-285.
170. Jones R, Zapol WM, Reid LM. Oxygen toxicity and restructuring of pulmonary arteries. A morphometric study. Am J Pathol 1985; 121:212-223.
171. Kaapa P, Seppanen M, Kero P, Saraste M. Pulmonary hemodynamics after synthetic surfactant replacement in neonatal RDS. J Pediatr 1993; 123:115-119.
172. Karakurum M, Shreeniwas R, Chen J, Pinsky D, Yan S-D, Anderson M, Sunouchi K, Major J, Kuwabara K, Rot A, Nowygrod R, Stern D. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994; 93: 1564-1570.
173. Katambi T, Shimizu M, Okan K, Yano Y, Nemotol K, Ogura M, Tsukamoto T, Suzuki S, Ohira K, Yamada Y, Sekita N, Yoshida A, Someya K. Intracelluar signal transduction for interleukin-1P induced endothelin production in human umbilical vein endothelial cells. Biochem Biophys Res Commun 1992; 188:565-570.
174. Kavanaugh BP, Mouchawar A, Goldsmith J, Pearl RG. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced lung injury. J Appl Physiol 1994; 76:1324-1329.
175. Kay JM. Effect of intermittent normoxia on chronic hypoxic pulmonary hypertension, right ventricular hypertrophy, and polycythemia in rats. Am Rev Respir Dis 1980; 121:993-1001.
176. Khoury J, Langleben D. PAF stimulates lung pericyte growth in vitro. Am J Physiol 1996; 270:L298-304.
177. Kinsella JP, Halbower AC, Ziegler JW, Fox JF, Ivy DD, Abman SH. Low dose inhaled NO improves gas exchange without increasing vascular permeability in experimental HMD. Pediatr Res 1995; 37:337A.
178. Kinsella JP, Ivy DD, Abman SH. Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation. Am J Physiol 1994; 267: H1955-1961.
179. Kinsella JP, Ivy DD, Abman SH. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res 1994; 36:402-408.
180. Kinsella JP, Gerstmann DR, deLemos RA. Circulatory changes following premature delivery in a baboon model of HMD. Am J Physiol 1991; H1148-1154.
181. Kinsella JP, McQueston JA, Rosenberg AA, Abman SH. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. Am J Physiol 1992; 263:H875-880.
182. Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y. ET stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238:249-252.
183. Koops BL, Abman SH, Accurso FJ. Outpatient management and follow-up of BPD. Clin Perinatol 1984; 11:101-122.
184. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endo- thelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991; 88:1054-1057.
185. Kourembanas D, McQuillan L, Leung G, Faller D. NO regulates the expression of vasoconstrictors and growth factors by vascular endothelium under normoxia and hypoxia. J Clin Invest 1993; 92:99-104.
186. Kramer GL, Wells JN. Effects of phosphodiesterase inhibitors on cyclic nucleotide levels and relaxation of pig coronary arteries. Mol Pharmacol 1979; 16:813-822.
187. Kubes P, Granger DN. NO modulates microvascular permeability. Am J Physiol 1992; 262:H611-615.
188. Kubes P, Suzuki M, Granger DN. NO: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-4655.
189. Kunkel SL, Standiford T, Metinko AP, Streiter RM. Endothelial cell-derived novel chemotactic cytokines. In: Johnson A, Ferro TJ, eds. Lung Vascular Injury. Marcel Dekker 1992: 213-226.
190. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, Granger DN. Inhibition of NO production: mechanisms of vascular albumin leakage. Circ Res 1993; 73:164-171.
191. Langston C, Kida K, Reed M, et al. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984; 129:607-613.
192. LeCras TD, Xue C, Rengesamy A, Johns RA. Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung. Am J Physiol 1996; 270:L164-170.
193. Leffler CW, Hessler JR, Green RS. Mechanism of stimulation of pulmonary prostacyclin synthesis at birth. Prostaglandins 1984; 28:877-887.
194. Leffler CW, Tyler TL, Cassin S. Effect of indomethacin on pulmonary vascular response to ventilation of fetal goats. Am J Physiol 1978; 234:H346-351.
195. Lerman A, Sandok EK, Hildebrand FL, Burnett JC. Inhibition of EDRF enhances endothelin-mediated vasoconstriction. Circulation 1992; 85:1894-1898.
196. Levin DL, Hyman AI, Heymann MA, Rudolph AM. Fetal hypertension and the development of increased pulmonary vascular smooth muscle: a possible mechanism for persistent pulmonary hypertension of the newborn infant. J Pediatr 1978; 92:265-269.
197. Lewis AB, Heymann MA, Rudolph AM. Gestational changes in pulmonary vascular responses in fetal lambs in utero. Circ Res 1976; 39:536-541.
198. Li H, Chen S, Chen Y, Meng Q, Durand J, Oparil S, Elton T. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol 1994; 77:1451-1459.
199. Lincoln TM, Cornwell TL. Towards an understanding of the mechanism of action of cAMP and cGMP in smooth muscle relaxation. Blood Vessels 1991; 28:129-137.
200. Lonnquist PA, Jonsson B, Winberg P, Frostell CG. Inhaled NO in infants with developing or established chronic lung disease. Acta Paediatr 1995; 84:1188-1192.
201. Lopez-Farre A, Riesco A, Alvarez V, Egido J, Echefarreta G, Gallego MJ, Mouton M, Blum G, Gomez-Garre D, Iternando L, Sanchez-Madrid F, Casado S, Caramelo C. Endothelin stimulates human PMN adhesion to endothelial cells. Regulation by cGMP. Nephrol Dial Transplant 1992; 7:674-675A.
202. MacCumber MW, Ross CA, Glaser BM, Snyder SH. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 1989; 86:7285.
203. Margraf LR, Tomashefski JF, Bruce MC, Dahms BB. Morphometric analysis of the lung in BPD. Am Rev Respir Dis 1991; 143:391-400.
204. Massaro D, Teich N, Maxwell S, Massaro GD, Whitney P. Postnatal development of alveoli: regulation and evidence for a critical period in rats. J Clin Invest 1985; 76:1297-1305.
205. Massaro GD, Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol, 1996; 270:L305-310.
206. Malek AM, Greene AL, Izumo S. Regulation of endothelin-1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc Natl Acad Sci USA 1993; 90:5999-6003.
207. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNFa. Am J Physiol 1992; 262:C854-861.
208. McCullough PR, Forket PG, Froese AB. Lung volume maintenance prevents lung injury during HFOV in surfactant-deficient rabbits. Am Rev Respir Dis 1988; 137: 1185-1192.
209. McIntosh N, Walters RO. Effect of tolazoline in severe HMD. Arch Dis Child 1979; 54:105-110.
210. McQueston JA, Cornfield DN, McMurtry IF, Abman SH. Effects of oxygen and exogenous L-arginine on endothelium-derived relaxing factor activity in the fetal pulmonary circulation. Am J Physiol 1993; 264:H865-871.
211. McQueston JA, Kinsella JP, Ivy DD, McMurtry IF, Abman SH. Chronic pulmonary hypertension in utero impairs endothelium-dependent vasodilation. Am J Physiol 1995; 268:H288-294.
212. Melot C, Hallemans R, Naije R, et al. Deleterious effects of nifedipine on pulmonary gas exchange in COPD. Am Rev Respir Dis 1984; 130:612-616.
213. Meny RG, Blackmon L, Fleischmann D, Gutberlet R, Naumberg E. Sudden infant death and home monitors. Am J Dis Child 1988; 142:1037-1040.
214. Merrit TA, Stuard ID, Puccia J, Wood B, Edwards DK, Finkelstein J, Shapiro DL. Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and BPD. J Pediatr 1981; 98:949-956.
215. Merrit TA, Cochrane CG, Holcomb K, et al. Elastase and alpha-1-antiproteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 1983; 72:656-662.
216. Michel T, Li GK, Busconi L. Phosphorylation and subcellular translocation of endothelial NO synthase. Proc Natl Acad Sci USA 1993; 90:6252-6256.
217. Mitchell SH, Teague G. Reduced gas transfer at rest and during exercise in school age survivors of BPD. Am J Respir Crit Care Med 1998; 157:1406-1412.
218. Miyauchi T, Yorikane R, Sakail S, Sakurai T, Okada M, Nishikibe M, Yand M, Yamaguchi I, Sugishita Y, Goto K. Contribution of endogenous ET-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 1993; 73:887-897.
219. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142.
220. Morbidelli L, Chang C-H, Douglas JG, Granger HJ, Maggi CA, Geppetti P, Leddal F. NO mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996; 270:H411-415.
221. Morin FC, Egan EA, Ferguson W, Lundgren CEG. Development of pulmonary vascular response to oxygen. Am J Physiol 1988; 254:H542-546.
222. Morin FC. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res 1989; 25:245-250.
223. Moss AJ, Emmanouilides GC, Rettori O, Higashino SM, Adams FH. Postnatal circulatory and metabolic adjustments in normal and distressed premature infants. Biol Neonate 1965; 8:177-197.
224. Moyer-Mileur LJ, Nielson DW, Pfeffer KD, Witte MK, Chapman DL. Eliminating sleep-associated hypoxemia improves growth in infants with BPD. Pediatrics 1996; 98:779-783.
225. Muscedere JG, Mullen JBM, Gaw K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994; 149:1327-1334.
226. Nagao T, Vanhoutte PM. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations. Am J Respir Cell Mol Biol 1993; 8:1-6.
227. North AJ, Star RA, Brannon TS, Ujiie K, Wells LB, Lowenstein CJ, Snyder SH, Shaul PW. NO synthase type I and type III gene expression are developmentally regulated in rat lung. Am J Physiol 1994; 266:L635-641.
228. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of HMD. N Engl J Med 1967; 276:357-368.
229. Northway WH, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlick PT, Eichler I, Lamm RL, Brown BW. Late pulmonary sequelae of BPD. N Engl J Med. 1990; 323:1793-1799.
230. Obara H, Hoshino Y, Mori M, Mikawa K, Iwai S. Endothelium-dependent relaxation in isolated pulmonary arteries from rabbits exposed to hyperoxia. Crit Care Med 1989; 17:780-785.
231. O’Brodovich HM, Mellins RB BPD. Am Rev Respir Dis 1985; 132:694-709.
232. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984; 130: 817-821.
233. Ohlstein EH, Douglas SA. Endothelin-1 modulates vascular smooth muscle structure and vasomotion: implications in cardiovascular pathology. Drug Dev Res 1993; 29:108-128.
234. Olschewski H, Walmarth D, Schermuly R, Ghofrani A, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996; 124:820-824.
235. Ono S, Westcott JY, Voelkel NF. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J Appl Physiol 1992; 73:10841092.
236. Packer CS, Rhoades RA. Impaired pulmonary vascular smooth muscle function in lung injury. In: Johnson A, Ferro TJ, eds. Lung Vascular Injury. New York: Marcel Dekker, 1992:227-262.
237. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:646-666.
238. Parker JC, Hernandez LA, Longnecker GL, et al. Lung edema caused by high peak inspiratory pressures in dogs: role of increased microvascular filtration pressure and permeability. Am Rev Respir Dis 1990; 142:321-328.
239. Peliowski A, Finer NN, Etche PC, Tierney AJ, Ryan CA. Inhaled NO for premature neonates after prolonged rupture of the membranes. J Pediatr 1995; 126:450-453.
240. Phillips PG, Tsan M-F. Cytoarchitectural aspects of endothelial barrier function in reponse to oxidants and inflammatory mediators. In: Johnson A, Ferro TJ, eds. Lung Vascular Injury. New York: Marcel Dekker, 1992:113-135.
241. Pinney MA, Cotton EK Home management of BPD. Pediatrics 1978; 61:856-859.
242. Pohl U, Herlan K, Huang A, Bassenge E. EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries. Am J Physiol 1991; 261:H2016-H2023.
243. Post J, Hume J, Archer S, Weir EK. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol 1992; 262:C882-C890.
244. Pusey VA, MacPherson RI, Chernick V. Pulmonary fibroplasia following prolonged artificial ventilation of newborn infants. Can Med Assoc J 1969; 100:451-457.
245. Puy RJM, Hyde RW, Fisher AB, Clark JM, Dickson J, Lambertsan CJ. Alterations in the pulmonary capillary bed during early O2 toxicity in man. J Appl Physiol 1968; 24:537-543.
246. Quast U, Guillon J-M, Cavero I. Cellular pharmacology of potassium channel openers in vascular smooth muscle. Cardiovasc Res 1994; 28:805-810.
247. Rabinovitch M. Hypoxia and pulmonary vascular development. In: Haddad GG, Lister G, eds. Tissue Oxygen Deprivation. New York: Marcel Dekker, 1996:307-333.
248. Rabinovitch M, Gamble WJ, Miettinen OS, et al. Age and sex influence on pulmonary hypertension and on recovery. Am J Physiol 1981; 240:H1462-H1472.
249. Rabinovitch M, Gamble WJ, Nadas AS, et al. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 1979; 236: H818-827.
250. Rabinovitch M, Konstam MA, Gamble WJ, Papanicolaou N, Aronovitz MJ, Treves
251. S, Reid L. Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats. Circ Res 1983; 52:432-441.
252. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327:76-81.
253. Roberts JD, Chen T, Kawai N, Wain J, Dupuy P, Shimouchi A, Bloch K, Polaner D, Zapol WM. Inhaled NO reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 1993; 72:246-254.
254. Roberts RJ, Weesner KM, Bucher JR. O2 induced alterations in lung vascular development in the newborn rat. Pediatr Res 1983; 17:368-375.
255. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Abman SH. Increased immunoreactive endothelin-1 levels in persistent pulmonary hypertension of the newborn. J Pediatr 1993; 123:109-114.
256. Rossaint R, Falke KJ, Lopez F, Slama K, Pisonand U, Zapol WM. Inhaled NO in ARDS. N Engl J Med 1993; 328:399-405.
257. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium- derived relaxing factor. Am J Physiol 1986; 250:H822-827.
258. Rudolph AM. Fetal and neonatal pulmonary circulation. Annu Rev Physiol 1979; 41:383-395.
259. Rudolph AM, Drorbaugh JE, Auld PAM, et al. Studies on the circulation in the neonatal period. The circulation in the RDS. Pediatrics 1961; 27:551-556.
260. Rudolph AM, Heymann MA, Lewis AB. Physiology and pharmacology of the pulmonary circulation in the fetus and newborn. In: Hodson W, ed. Development of the Lung. New York: Marcel Dekker, 1977:497-523.
261. Sarker R, Webb C, Stanley JC. NO inhibition of endothelial cell mitogenesis and proliferation. Surgery 1995; 118:274-279.
262. Schwartz SM, Liaw L. Growth control and morphogenesis in the development and pathology of arteries. J Cardiovasc Pharmacol 1993; 2:S31-49.
263. Segerer H, Stevens P, Schadow B, Meir R, Kattner E, Schwartx H, Curstedt T, Robertson B, Obladen M. Surfactant substitution in ventilated very low birth weight infants: factors related to response type. Pediatr Res 1991; 30:591-596.
264. Sekar KD, Duke JC. Sleep apnea and hypoxemia in recently weaned premature neonates with and without BPD. Pediatr Pulmonol 1991; 10:112-116.
265. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamic effects of inhaled NO in heart failure. J Am Coll Cardiol 1994; 24:982-988.
266. Seldinger SR, Kennedy TP, Buescher P, et al. Effects of removing oxygen from patients with COPD. Am Rev Respir Dis 1987; 136:85-91.
267. Seppanen MP, Kaapa PO, Kero PO. Hemodynamic prediction of complications in neonatal respiratory distress syndrome. J Pediatr 1995; 127:780-785.
268. Shankaran S, Fanaroff AA, Wright LL, et al. Characteristics of early (12 hour) death among VLBW neonates. Pediatr Res 1995; 37:236A.
269. Shasby DM, Fox RB, Harada RN, Repine JE. Reduction of the edema of acute hyperoxic lung injury by granulocyte depletion. J Appl Physiol 1982; 52:1237-1244.
270. Shaul PW, Farrer MA, Zellers TM. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries. Am J Physiol 1992; 262:H355-364.
271. Shaul PW, Campbell WB, Farrer MA, Magness RR. Oxygen modulates prostacyclin synthesis in ovine fetal pulmonary arteries by an effect on cyclooxygenase. J Clin Invest 1992; 90:2147-2155.
272. Singer L, Martin RJ, Hawkins SW, Benson-Szekely LJ, Yamashita T, Carlo WA. Oxygen desaturation complicates feeding in infants with BPD after discharge. Pediatrics 1992; 90:380-384.
273. Skinner JR, Boys JR, Hunter S, Hey EN. Pulmonary and systemic arterial pressure in HMD. Arch Dis Child 1992; 67:366-373.
274. Smyth JA, Tabachnik E, Duncan WJ, Reilly RJ, Levison H. Pulmonary function and bronchial hyperactivity in long-term survivors of BPD. Pediatrics 1981; 68: 336-340.
275. Sobonya RE, Logvinoff MM, Taussig LM, Theriault A. Morphometric analysis of the lung in prolonged BPD. Pediatr Res 1982; 16:969-972.
276. Soifer SJ, Kaslow D, Roman C, Heymann MA. Umbilical cord compression produces pulmonary hypertension in newborn lambs. J Dev Physiol 1987; 9:239-252.
277. Soifer SJ, Loitz RD, Roman C, Heymann MA. Leukotriene end organ antagonists increase pulmonary blood flow in fetal lambs. Am J Physiol 1985; 249:H570-576.
278. Sole MJ, Drobac M, Schwartz L, et al. Extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension. Circulation 1979; 60:160-163.
279. Southall DP, Samuels MP, Talbert DG. Recurrent cyanotic episodes with severe arterial hypoxaemia and intrapulmonary shunting: a mechanism for sudden death. Arch Dis Child 1990; 65:953-961.
280. Stahlman M. Treatment of cardiovascular disorders of the newborn. Pediatr Clin N Am 1964; 11:363-400.
281. Stahlman M, Blankenship WJ, Shepard FM, Gray J, Young WC, Malan AF. Circulatory studies in clincal HMD. Biol Neonate 1972; 20:300-320.
282. Steinhorn RH, Russell JA, Morin FC. Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. Am J Physiol 1995; 268:H1483-1489.
283. Stelzner T, O’Brien R, Yanagasawa M, Sakurai T, Sato K, Webb S, Zamora M, McMurtry I, Fisher J. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am J Physiol 1992; 262:L614-620.
284. Stenmark KR, Abman SH, Accurso FJ. Etiologic mechanisms of persistent pulmonary hypertension of the newborn. In: Weir EK, Reeves JT, eds. Pulmonary Vascular Physiology and Pathophysiology. New York: Marcel-Dekker, 1989:335.
285. Stenmark KR, Dempsey EC, Badesch DB, Frid M, Mecham RP, Parks WC. Regulation of pulmonary vascular wall cell growth developmental and site specific heterogeneity. Eur Respir Rev 1993; 3:629-637.
286. Stenmark KR, Eyzaguirre M, Westcott JY, et al. Potential role of eicosanoids and platelet activating factor in the pathophysiology of BPD. Am Rev Respir Dis 1987; 136:770-772.
287. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease. Ann Intern Med 1991; 114:464-469.
288. Stocker JT. Pathology of long-standing “healed” BPD. Hum Pathol 1986; 17:943-961.
289. Taghizadeh A, Reynolds EOR. Pathogenesis of BPD following HMD. Am J Pathol 1976; 82:241-258.
290. Tanswell AK, Freeman BA. Pulmonary antioxidant enzyme maturation in the fetal and neonatal rat. 1: developmental profile. Pediatr Res 1984; 18:584-587.
291. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 1990; 346:69-71.
292. Tomashefski JF, Opperman HC, Vawter GF. BPD: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol 1984; 2:469-487.
293. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994; 144:275-285.
294. Voelkel NF, Tuder RM, Wade K, Hoeper M, Lepley RA, Goulet JL, Koller BH, Fitzpatrick F. Inhibition of 5-lipoxygenase-activating protein reduces pulmonary vascular reactivity and pulmonary hypertension. J Clin Invest 1996; 97:2491-2498.
295. Tyler RC, Muramatsu M, Abman SH, Stelzner TJ, Rodman DM, Bloch KD, McMurtry IF. Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension. Am J Physiol 1999; 276: in press.
296. Velvis H, Moore P, Heymann MA. Prostaglandin inhibition prevents the fall in pulmonary vascular resistance as the result of rhythmic distension of the lungs in fetal lambs. Pediatr Res 1991; 30:62-67.
297. Vender RL. Chronic hypoxic pulmonary hypertension. Chest 1994; 106:236-243.
298. Villamor E, Le Cras TD, MB Horan, AC Halbower, RM Tuder, Abman SH. Chronic intrauterine pulmonary hypertension impairs eNOS in the ovine fetus. Am J Physiol 1997; 272:L1013-1020.
299. Voelkel NF, Tuder RM. Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation. Ann NY Acad Sci 1994; 725:104-109.
300. Voelkel NF, Tuder RM, Wade K, Hoper M, Goulet J, Koller B, Fitzpatrick F. Inhibition of 5-lipoxygenase protein reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J Clin Invest 1996; 97:2491-2498.
301. Wang Y, Coceani F. Isolated pulmonary resistance vessels from fetal lambs: contractile behavior and responses to indomethacin and endothelin-1. Circ Res 1992; 71:320-330.
302. Wallen LD, Perry SF, Alston JT, Maloney JE. Morphometric study of the role of pulmonary arterial flow in fetal lung growth in sheep. Pediatr Res 1990; 27:122-127.
303. Walther FJ, Bender FJ, Leighton JO. Persistent pulmonary hypertension in premature neonates with severe RDS. Pediatrics 1992; 90:899-904.
304. Webb HH, Tierney DF. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressure. Protection by PEEP. Am Rev Re- spir Dis 1974; 110:556-565.
305. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled NO and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88:2128-2138.
306. Westhammer J, Brown ER, Neff RK, Taeusch HW. Sudden infant death syndrome in infants with BPD. Pediatrics 1982; 69:301-304.
307. White CW, Repine JE. Pulmonary antioxidant defense mechanisms. Exp Lung Res 1985; 8:81-96.
308. Wilson WL, Mullen M, Olley PM, Rabinovitch M. Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery. Pediatr Res 1985; 19:1059-1067.
309. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB. NO protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 1993; 90:9813-9817.
310. Wong J, Fineman JR, Heymann MA. The role of endothelin and endothelin receptor subtypes in regulation of fetal pulmonary vascular tone. PediatrRes 1994; 35:664-670.
311. Xuan ATD, Higgenbottom TW, Pepke-Zaba J, Clelland C, Wallwork J. Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries. Eur J Pharmacol 1989; 163:401-403.
312. Xuan ATD, Higgenbottom TW, Clelland C, Pepke-Zaba J, Cremona G, Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger’s syndrome. Br J Pharmacol 1989; 99:9-10.
313. Yokokawa K, Tahara H, Kohno M, Mandal AK, Yanagaswa M, Takeda T. Heparin regulates endothelin production through endothelium-derived NO in human endothelial cells. J Clin Invest 1993; 92:2080-2085.
314. Yoshimoto S, Ishizaki Y, Sasaki T, Murota S-I. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 1991; 22:378-383.
315. Yoshizumi M, Kurihara H, Morita T, Yamashita T, Oh-hashi Y, Sugiyama T, Ta- kaku F, Yanagisawa M, Masaki T, Yazaki Y. Interleukin-1 increases the production of ET-1 by cultured endothelial cells. Biochem Biophys Res Commun 1990; 181: 529-536.
316. Yoshizumi M, Kurihara H, Sugiyama T, Yamaoki K, Takaku F, Satoh H, Inu J, Yanagisawa M, Masakik T, Yazaki Y. Hemodynamic shear stress simulates endo- thelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989; 161:859-864.
317. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
318. Yokokawa K, Tahara H, Kohno M, Mandal AK, Yanagisawa M, Takeda T. Heparin regulates endothelin production through endothelium-derived NO in human endothelial cells. J Clin Invest 1993; 92:2080-2085.
319. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F. NO mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94:2036-2044.
320. Ziegler JW, Ivy OD, Fox J, Kinsella JP, Clarke WR, Abman SH. Dipyridamole, a cGMP phosphodiesterase inhibitor augments inhaled NO-induced pulmonary vasodilation in the ovine transitional circulation. Am J Respir Crit Care Med 1998; 157:1104-1110.
321. Zhu L, Wigle D, Hinek A, Koboyashi J, Ye C, Zuker M, Dodo H, Keeley F, Rabi- novitch M. The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. J Clin Invest 1994; 94:1163-1171.